Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma.
Wang C, Li Y, Chu CM, Zhang XM, Ma J, Huang H, Wang YN, Hong TY, Zhang J, Pan XW, Zheng JC, Jiang N, Hu CY, Ma X, Sun YH, Cui XG.
Wang C, et al. Among authors: wang yn.
EBioMedicine. 2019 Jan;39:255-264. doi: 10.1016/j.ebiom.2018.12.011. Epub 2018 Dec 14.
EBioMedicine. 2019.
PMID: 30558998
Free PMC article.